Vistagen Therapeutics (VTGN.MX) Q1 2026 Earnings

Feb 12Confirmed
Q1 2026
-8.38
-8.17
-7.96
-7.75

Details

Expected EPS
-8.381371415999999
Actual EPS
-7.7465025
Surprise EPS
0.63
Surprise Percent
+7.57%

Description

⁨Vistagen Therapeutics⁩ (⁦VTGN.MX⁩) has reported earnings of ⁦-7.7465025⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts